PEOPLE - Cardio Technologies makes the following organisational changes:
This article was originally published in Clinica
US critical care products manufacturer Cardio Technologies has made the following organisational changes. Thomas Wood becomes president and CEO, and Lawrence Bartz vice-president of finance and chief financial officer. Both are from US Surgical. John Bichan joins as vice-president marketing from Genzyme Surgical Products, and Robert Reinhardt as director of engineering from Cordis.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.